Condition
Recurrent Respiratory Papillomatosis (RRP)
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Gardasil9 Human Papillomavirus 9valent Vaccine Recombinant
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 1/2 (1)
Phase 3 (1)
Trial Status
Not Yet Recruiting2
Clinical Trials (2)
Showing 2 of 2 trials
NCT07901738Phase 3Not Yet RecruitingPrimary
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
NCT07339163Phase 1/2Not Yet RecruitingPrimary
Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis*
Showing all 2 trials
Research Network
Common Treatments
- Gardasil9 Human Papillomavirus 9valent Vaccine Recombinant1
- Zopapogene Imadenovecdrba1
Active Sponsors
- Precigen, Inc1
- Merck Sharp & Dohme LLC1
- Ohio State University1
Top Investigators
Ohio State University
Related Conditions
- Juvenileonset Recurrent Respiratory Papillomatosis1
- Papillomavirus Infections1